New drug 'selectively kills dormant cancer cells'
2/19/2014
New research published in Nature Communications details the discovery of a potential new drug that selectively kills dormant cancer cells in tumors by inducing mitochondrial dysfunction.The research team, led by Prof.
Predicting presence of breast cancer through small non-coding RNAs
2/19/2014
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO Reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues.
Targeting stem cells in triple-negative breast cancer
2/19/2014
New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease.
New drug 'selectively kills dormant cancer cells'
2/19/2014
New research published in Nature Communications details the discovery of a potential new drug that selectively kills dormant cancer cells in tumors by inducing mitochondrial dysfunction.The research team, led by Prof.
Predicting presence of breast cancer through small non-coding RNAs
2/19/2014
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO Reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues.
Targeting stem cells in triple-negative breast cancer
2/19/2014
New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease.
Globally, cancer kills 50% more men than women
2/18/2014
Figures published by Cancer Research UK reveal that more than 4.6 million men and 3.5 million women die of cancer worldwide every year, putting the global rate of cancer death among men (126 per 100,000) 50% higher than that of women (82 per 100,000).
Post-surgery heart attack: '85% undetected due to lack of symptoms'
2/18/2014
According to a study published in the journal Anesthesiology, over 8 million adults worldwide have injuries or heart attacks after surgery each year, with 10% dying within 30 days. Now, researchers say 85% of these heart attacks or injuries may be missed due to lack of symptoms. However, they suggest this could be resolved with a simple blood test following surgery.
Post-surgery heart attack: '85% undetected due to lack of symptoms'
2/18/2014
According to a study published in the journal Anesthesiology, over 8 million adults worldwide have injuries or heart attacks after surgery each year, with 10% dying within 30 days. Now, researchers say 85% of these heart attacks or injuries may be missed due to lack of symptoms. However, they suggest this could be resolved with a simple blood test following surgery.
Nanofiber 'monorails' ferry brain tumors to their death
2/18/2014
Glioblastoma is the deadliest form of brain cancer, and one reason it is difficult to treat is because tumor cells spread to other parts of the brain by following nerve fibers and blood vessels. Now, using nanofiber "monorails," biomedical engineers have found a way to hijack this migratory feature and lure the malignant cells elsewhere.